Hepcinat

Hepcinat is a prescription antiviral medication formulated with Sofosbuvir (400 mg). It belongs to a class of drugs known as nucleotide polymerase inhibitors and is a breakthrough therapy used primarily for the treatment of chronic Hepatitis C virus (HCV) infections. The active ingredient works directly by blocking the RNA polymerase enzyme that the Hepatitis C virus requires to replicate itself inside the body. By stopping viral replication, Hepcinat effectively lowers the viral load to undetectable levels, helping to halt the progression of liver diseases like cirrhosis and liver cancer. It is typically prescribed as part of a combination regimen alongside other antiviral agents.